<DOC>
	<DOCNO>NCT01644422</DOCNO>
	<brief_summary>This multicentre , open label , randomize , pilot study evaluate safety efficacy Human Platelet Lysate ( HPL ) subject Androgenetic Alopecia undergo hair transplantation . The study conduct 2 center India . The primary endpoint Increase Hair Follicle viability transplant , Improvement Caliber &amp; Density hair Improvement Photographic assessment randomization end study . The secondary endpoint Physicians Patients self assessment score .</brief_summary>
	<brief_title>Study To Determine Safety &amp; Efficacy Of Autologous Human Platelet Lysate Androgenetic Alopecia After Hair Transplant</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Male subject , age 18 50 year ( inclusive ) general good health Subjects willing refrain AGA treatment entire study duration Subjects willing give inform consent adhere study protocol Subjects age &lt; 18 &gt; 50 year Subjects dermatological disorder scalp might interfere study evaluation Subjects Anticoagulant therapy Subjects clinically significant medical psychiatric disease determine investigator . Subjects unwilling unable comply study protocol . Subjects take concomitant therapy might interfere study result investigator opinion participate another trial past 30 day .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>